MA31003B1 - Inhibiteurs de renine pour la prevention et le traitement de l'hypertension chez les patients obeses - Google Patents
Inhibiteurs de renine pour la prevention et le traitement de l'hypertension chez les patients obesesInfo
- Publication number
- MA31003B1 MA31003B1 MA32007A MA32007A MA31003B1 MA 31003 B1 MA31003 B1 MA 31003B1 MA 32007 A MA32007 A MA 32007A MA 32007 A MA32007 A MA 32007A MA 31003 B1 MA31003 B1 MA 31003B1
- Authority
- MA
- Morocco
- Prior art keywords
- prevention
- hypertension
- obese patients
- treatment
- renin inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
LA PRÉSENTE INVENTION CONCERNE DES PROCÉDÉS DE PRÉVENTION, DE RETARD DE PROGRESSION OU DE TRAITEMENT DE L'HYPERTENSION CHEZ DES PATIENTS OBÈSES, COMPRENANT L'ADMINISTRATION À UN ANIMAL À SANG CHAUD D'UNE QUANTITÉ THÉRAPEUTIQUEMENT EFFICACE D'UN INHIBITEUR DE RÉNINE TEL QUE L'ALISKIRÈNE OU D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE. L'INHIBITEUR DE RÉNINE PEUT ÊTRE UTILISÉ SEUL OU EN COMBINAISON AVEC UN AUTRE ANTIHYPERTENSEUR, EN PARTICULIER UN DIURÉTIQUE TEL QUE L'HYDROCHLOROTHIAZIDE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87018006P | 2006-12-15 | 2006-12-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA31003B1 true MA31003B1 (fr) | 2009-12-01 |
Family
ID=39186152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA32007A MA31003B1 (fr) | 2006-12-15 | 2009-06-17 | Inhibiteurs de renine pour la prevention et le traitement de l'hypertension chez les patients obeses |
Country Status (18)
Country | Link |
---|---|
US (1) | US20100029775A1 (fr) |
EP (1) | EP2094259A1 (fr) |
JP (1) | JP2010513300A (fr) |
KR (1) | KR20090090384A (fr) |
CN (1) | CN101583355A (fr) |
AU (1) | AU2007333095B2 (fr) |
BR (1) | BRPI0721167A2 (fr) |
CA (1) | CA2672579A1 (fr) |
CL (1) | CL2007003628A1 (fr) |
IL (1) | IL198876A0 (fr) |
MA (1) | MA31003B1 (fr) |
MX (1) | MX2009006340A (fr) |
NO (1) | NO20092597L (fr) |
RU (1) | RU2009126741A (fr) |
TN (1) | TN2009000240A1 (fr) |
TW (1) | TW200831071A (fr) |
WO (1) | WO2008074001A1 (fr) |
ZA (1) | ZA200903442B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2143425A1 (fr) * | 2008-07-11 | 2010-01-13 | Ratiopharm GmbH | Tablettes d'aliskiren comprimées directement |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
AR047880A1 (es) * | 2004-02-17 | 2006-03-01 | Novartis Ag | COMBINACIoN DE UN INHIBIDOR DE RENINA Y DIURÉTICOS |
TW200605867A (en) * | 2004-03-17 | 2006-02-16 | Novartis Ag | Use of organic compounds |
WO2007047351A2 (fr) * | 2005-10-13 | 2007-04-26 | Orexigen Therapeutics, Inc. | Méthodes pour traiter l'hypertension chez des individus en surpoids et obèses |
CA2655144A1 (fr) * | 2006-06-15 | 2007-12-21 | Gilead Colorado, Inc. | Procede de traitement antihypertenseur |
-
2007
- 2007-12-13 AU AU2007333095A patent/AU2007333095B2/en not_active Ceased
- 2007-12-13 US US12/519,189 patent/US20100029775A1/en not_active Abandoned
- 2007-12-13 EP EP07865611A patent/EP2094259A1/fr not_active Withdrawn
- 2007-12-13 CN CNA2007800499179A patent/CN101583355A/zh active Pending
- 2007-12-13 KR KR1020097014655A patent/KR20090090384A/ko not_active Application Discontinuation
- 2007-12-13 WO PCT/US2007/087322 patent/WO2008074001A1/fr active Application Filing
- 2007-12-13 MX MX2009006340A patent/MX2009006340A/es not_active Application Discontinuation
- 2007-12-13 CA CA002672579A patent/CA2672579A1/fr not_active Abandoned
- 2007-12-13 BR BRPI0721167-8A patent/BRPI0721167A2/pt not_active IP Right Cessation
- 2007-12-13 JP JP2009541572A patent/JP2010513300A/ja not_active Withdrawn
- 2007-12-13 RU RU2009126741/15A patent/RU2009126741A/ru not_active Application Discontinuation
- 2007-12-14 CL CL200703628A patent/CL2007003628A1/es unknown
- 2007-12-14 TW TW096148110A patent/TW200831071A/zh unknown
-
2009
- 2009-05-19 ZA ZA200903442A patent/ZA200903442B/xx unknown
- 2009-05-21 IL IL198876A patent/IL198876A0/en unknown
- 2009-06-12 TN TNP2009000240A patent/TN2009000240A1/fr unknown
- 2009-06-17 MA MA32007A patent/MA31003B1/fr unknown
- 2009-07-08 NO NO20092597A patent/NO20092597L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CL2007003628A1 (es) | 2008-07-18 |
MX2009006340A (es) | 2009-06-23 |
EP2094259A1 (fr) | 2009-09-02 |
TW200831071A (en) | 2008-08-01 |
KR20090090384A (ko) | 2009-08-25 |
NO20092597L (no) | 2009-07-13 |
IL198876A0 (en) | 2010-02-17 |
WO2008074001A1 (fr) | 2008-06-19 |
TN2009000240A1 (en) | 2010-10-18 |
AU2007333095B2 (en) | 2011-03-24 |
RU2009126741A (ru) | 2011-01-20 |
WO2008074001A8 (fr) | 2009-07-02 |
US20100029775A1 (en) | 2010-02-04 |
BRPI0721167A2 (pt) | 2014-03-18 |
AU2007333095A1 (en) | 2008-06-19 |
JP2010513300A (ja) | 2010-04-30 |
CA2672579A1 (fr) | 2008-06-19 |
CN101583355A (zh) | 2009-11-18 |
ZA200903442B (en) | 2010-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA32684B1 (fr) | Dérivés de picolinamide en tant qu'inhibiteurs de kinase | |
MA32132B1 (fr) | Utilisation de ranolazine pour traiter la douleur | |
MA31205B1 (fr) | Combinaisons d'agents therapeutiques pour le traitement du cancer | |
MA31663B1 (fr) | Dosage oral et interveineux de l'inhibiteur p2y12 reverisble et a action directe | |
MA31396B1 (fr) | Therapie de combinaison avec un compose agissant comme inhibiteur de recepteur a l'adp de plaquettes | |
MA30128B1 (fr) | Combinaisons pharmaceutiques d'un antagoniste de receptuer d'angiotensine et d'un inhibiteur de nep | |
MA29915B1 (fr) | Benzimidazoles substitues utilises en tant qu'inhibiteurs de kinases | |
MA31707B1 (fr) | Dérivés de benzimidazole et d'indole substitués par de l'oxadiazole et oxazole comme inhibiteurs de dgat1 | |
MA33571B1 (fr) | Traitement de cellules tumorales astrocytaires avec des inhibiteurs de recepteurs d'endotheline | |
EP1606264A4 (fr) | Antagonistes des recepteurs du cgrp d'anilide spirohydantoine monocyclique | |
GEP20125691B (en) | Compounds and compositions as protein kinase inhibitors | |
MA30900B1 (fr) | Anticorps d'agonistes anti-notch3 et leur utilisation dans le traitement de maladies liées à notch3 | |
MX2007006066A (es) | Inhibidores de jnk para el tratamiento de lesiones del snc. | |
UA97795C2 (uk) | Дейтеровані похідні катехоламіну і медикаменти, що містять згадані сполуки | |
MA30085B1 (fr) | Traitement du diabete de type 2 avec une association d'un inhibiteur de dpiv et de metformine ou d'une thiazolidinedione | |
WO2007087151A3 (fr) | Méthode de traitement d'un dysfonctionnement cognitif | |
EA200100937A1 (ru) | Способы и композиции, использующие (-)-норцисаприд в комбинации с ингибиторами протонных насосов или антагонистами h2-рецепторов | |
NO20060328L (no) | Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser | |
EA200100936A1 (ru) | Способы и композиции, использующие (+)-норцисаприд в комбинации с ингибиторами протонных насосов или антагонистами h2-рецепторов | |
LU92282I2 (fr) | Telmisartan et/ou ses sels pharmacologiquement acceptables | |
MA31761B1 (fr) | Nouveaux inhibiteurs de seh et leur utilisation | |
MX2007004020A (es) | Uso de inhibidores de renina para la prevencion o tratamiento de disfuncion diastolica o falla cardiaca diastolica. | |
MA33602B1 (fr) | Composition pharmaceutique permettant de prévenir ou de traiter l'arthrite rhumatoïde, contenant du rébamipide | |
MA31003B1 (fr) | Inhibiteurs de renine pour la prevention et le traitement de l'hypertension chez les patients obeses | |
WO2008030595A3 (fr) | Traitement, prévention et élimination d'une hépatopathie alcoolique |